CARDIFF ONCOLOGY, INC. Debt and Lease Obligation
CARDIFF ONCOLOGY, INC. (CRDF) had Debt and Lease Obligation of $15.00 million as of 2013-12-31, per its 10-K filed 2015-03-12.
Discontinued › Balance Sheet › Liabilities › Debt
us-gaap:DebtAndCapitalLeaseObligations · last filed 2015-03-12
- 2013-12-31: Debt and Lease Obligation $15.00M; Debt and Lease Obligation as first filed $521.16K.
| Period end | Debt and Lease Obligation | Debt and Lease Obligation as first filed |
|---|---|---|
| 2013-12-31 | $15.00M 10-K · filed 2015-03-12 | $521.16K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |